Health care firms were advancing in early trading Monday with the Health Care SPDR (XLV) up 0.37% and the iShares NASDAQ Biotechnology Index (IBB) 0.36% higher recently.
Philips (PHG) was rallying past 5% even after it reported Q2 adjusted earnings of EUR0.35 ($0.40) per share, down from EUR0.42 per share in the prior-year period.
Pfizer (PFE) was up more than 3% and BioNTech (BNTX) was nearly 11% higher amid a deal with the United Kingdom to supply the country with 30 million doses of their BNT162 COVID-19 vaccine candidate.
Quotient (QTNT) was advancing by more than 3% after saying an independent study in Spain found that its MosaiQ COVID-19 antibody microarray demonstrated an "impressive" 100% sensitivity and 99.8% specificity.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Latest Markets Videos
Explore US Markets
ExploreMost Popular
- White House says Walmart, FedEx, UPS to work 24/7 to ease supply bottlenecks for holiday season
- Chinese online brokers Futu and UP Fintech face regulatory risks - People's Daily website
- September, Third Quarter 2021 Review and Outlook
- PRECIOUS-Gold eases as inflation data fans policy tightening bets